Zobrazeno 1 - 10
of 438
pro vyhledávání: '"B Bogardus"'
Autor:
Janssen, Joseph A. M. J. L.1 (AUTHOR) j.a.m.j.l.janssen@erasmusmc.nl
Publikováno v:
International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 24, p13238. 17p.
Autor:
Bontzorlos, Vasileios1 (AUTHOR) vasilibon@gmail.com, Cain, Shlomo2 (AUTHOR) shlomocain@gmail.com, Leshem, Yossi2 (AUTHOR) yossile@tauex.tau.ac.il, Spiegel, Orr2 (AUTHOR) orrspiegel@tauex.tau.ac.il, Motro, Yoav3 (AUTHOR) yoavmot@moag.gov.il, Bloch, Itai4 (AUTHOR) itaibloch2@gmail.com, Cherkaoui, Sidi Imad5 (AUTHOR) imad.cherkaoui@gmail.com, Aviel, Shaul6,7 (AUTHOR) aviel@biobee.com, Apostolidou, Melpo8 (AUTHOR) melpo.apostolidou@birdlifecyprus.org.cy, Christou, Antaia8 (AUTHOR) antaia.christou@birdlifecyprus.org.cy, Nicolaou, Harris9 (AUTHOR) nicolaouharis@cytanet.com.cy, Kassinis, Nikolaos10 (AUTHOR) lemesos.thira@cytanet.com.cy, Rashid, Mansour Abu11 (AUTHOR) acpd.aburashid@gmail.com, Bahdouhesh, Mary11 (AUTHOR) bahdoushehmary@gmail.com, Roulin, Alexandre12 (AUTHOR) alexandre.roulin@unil.ch
Publikováno v:
Conservation (2673-7159). Dec2024, Vol. 4 Issue 4, p627-656. 30p.
Publikováno v:
American Journal of Health-System Pharmacy. 47:512-519
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b724d9c219df228d5b0050fe9c7d5ec0
https://doi.org/10.1093/ajhp/47.3.512
https://doi.org/10.1093/ajhp/47.3.512
Autor:
Csenge, Halász, Balázs, Fejes József
Publikováno v:
Iskolakultúra; feb/mar2024, Vol. 34 Issue 2/3, p47-71, 25p
Autor:
Gao, Qi1 (AUTHOR), Jiang, Yingying1 (AUTHOR), Song, Zhenqiang1 (AUTHOR), Ren, Huizhu1 (AUTHOR), Kong, Yan1 (AUTHOR), Wang, Cong1 (AUTHOR), Zheng, Miaoyan1 (AUTHOR), Shan, Chunyan1 (AUTHOR) chunyanshan@hotmail.com, Yang, Yanhui1 (AUTHOR) yangyanhui@tmu.edu.cn
Publikováno v:
Scientific Reports. 7/23/2024, Vol. 14 Issue 1, p1-14. 14p.
Publikováno v:
Pharmaceutical research. 12(2)
Chimeric BR96-doxorubicin conjugate (BR96-DOX) is an immunoconjugate designed to specifically target and kill certain tumor cells. The linker between the chimeric BR96 antibody and DOX is an acid-labile hydrazone group which was designed to undergo l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0628272d5c3753d4fdb14969901a91cf
https://pubmed.ncbi.nlm.nih.gov/7784336
https://pubmed.ncbi.nlm.nih.gov/7784336
Publikováno v:
Pharmaceutical research. 11(5)
Chimeric L6 is a mouse-human monoclonal antibody specific for tumor cell-associated antigens. The factors affecting the physical and chemical stability of chimeric L6 were assessed at elevated temperatures (30-60 degrees C) and by multiple freezing a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f39f59f04b34b3b5acb3e2f6025ab8da
https://pubmed.ncbi.nlm.nih.gov/8058650
https://pubmed.ncbi.nlm.nih.gov/8058650
Autor:
B G Gold, B Bogardus
Publikováno v:
Journal of Neuropathology and Experimental Neurology. 58:545
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a421e7f1c262ee989e3d42c1ed464c12
https://doi.org/10.1097/00005072-199905000-00155
https://doi.org/10.1097/00005072-199905000-00155
Autor:
Li Chen1,2,3, Xi Chen3, Runwen Qi3, Tao Zhang2, Qiang Jiang2, Jiaming Ye3, Shaohong Zhang4, Wen Zhou3, Caiying Guo3, Jiang Huang3, Chao Liu1 profliuchao@163.com
Publikováno v:
Current Topics in Nutraceutical Research. Nov2023, Vol. 21 Issue 4, p350-355. 6p.
Autor:
Joseph B. Bogardus, N.R. Palepu
Publikováno v:
International Journal of Pharmaceutics. 4:159-170
Solution equilibria of an experimental antibiotic (code named CP-38, 371) were investigated. In the pH range 2–4 the compound has two pK values. These overlapping macroconstants were determined by three methods: potentiometric titration, spectro-me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::faf847602ce43418bf1b5a66c547050d
https://doi.org/10.1016/0378-5173(79)90064-4
https://doi.org/10.1016/0378-5173(79)90064-4